Literature DB >> 34741649

Magnesium intake is inversely associated with risk of non-alcoholic fatty liver disease among American adults.

Liping Lu1,2, Cheng Chen1,2, Yuexia Li3,4, Wenzhi Guo3,4, Shuijun Zhang3,4, John Brockman5, James M Shikany6, Ka Kahe7,8.   

Abstract

PURPOSE: Human data are limited linking magnesium (Mg) intake to the risk of non-alcoholic fatty liver disease (NAFLD). We aimed to examine the association between Mg intake and the risk of NAFLD among young adults in the US with a 25-year follow-up.
METHODS: This study included 2685 participants from the Coronary Artery Risk Development in Young Adult (CARDIA) study. Diet and dietary supplements were assessed at baseline (1985-1986) and exam years 7 and 20 using an interview-based dietary history. NAFLD, defined as liver attenuation ≤ 51 Hounsfield Units excluding secondary causes of liver fat accumulation, was identified by non-contrast-computed tomography scanning at exam year 25. Multivariable-adjusted logistic regression model was used to examine the associations between cumulative average total intake of Mg (dietary plus supplemental) and NAFLD odds.
RESULTS: A total of 629 NAFLD cases were documented. After adjustment for potential confounders, an inverse association between total Mg intake and NAFLD odds was observed. Compared to participants in the lowest quintile of total Mg intake, the odds of NAFLD was 55% lower among individuals in the highest quintile [multivariable-adjusted odds ratio (OR) = 0.45, 95% confidence interval (CI) (0.23, 0.85), p for trend = 0.03]. Consistently, whole-grain consumption, a major dietary source of Mg, was inversely associated with NAFLD odds (p for trend = 0.02).
CONCLUSIONS: This study suggests that higher cumulative intake of Mg throughout adulthood is associated with lower odds of NAFLD in midlife. Future studies are needed to establish a possible causal relationship.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany.

Entities:  

Keywords:  CARDIA; Diet; Magnesium; Non-alcoholic fatty liver disease; Supplement

Mesh:

Substances:

Year:  2021        PMID: 34741649     DOI: 10.1007/s00394-021-02732-8

Source DB:  PubMed          Journal:  Eur J Nutr        ISSN: 1436-6207            Impact factor:   5.614


  49 in total

1.  Magnesium deficiency and glucose metabolism in rat adipocytes.

Authors:  F R Kandeel; E Balon; S Scott; J L Nadler
Journal:  Metabolism       Date:  1996-07       Impact factor: 8.694

2.  Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009.

Authors:  Zobair M Younossi; Munkhzul Otgonsuren; Linda Henry; Chapy Venkatesan; Alita Mishra; Madeline Erario; Sharon Hunt
Journal:  Hepatology       Date:  2015-10-24       Impact factor: 17.425

3.  Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008.

Authors:  Zobair M Younossi; Maria Stepanova; Mariam Afendy; Yun Fang; Youssef Younossi; Hesham Mir; Manirath Srishord
Journal:  Clin Gastroenterol Hepatol       Date:  2011-03-25       Impact factor: 11.382

Review 4.  Effect of magnesium supplementation on insulin resistance in humans: A systematic review.

Authors:  Jennifer Beatriz Silva Morais; Juliana Soares Severo; Geórgia Rosa Reis de Alencar; Ana Raquel Soares de Oliveira; Kyria Jayanne Clímaco Cruz; Dilina do Nascimento Marreiro; Betânia de Jesus E Silva de Almendra Freitas; Cecília Maria Resende de Carvalho; Maria do Carmo de Carvalho E Martins; Karoline de Macedo Gonçalves Frota
Journal:  Nutrition       Date:  2017-02-02       Impact factor: 4.008

5.  Nonalcoholic Steatohepatitis Is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant Candidates.

Authors:  Zobair Younossi; Maria Stepanova; Janus P Ong; Ira M Jacobson; Elisabetta Bugianesi; Ajay Duseja; Yuichiro Eguchi; Vincent W Wong; Francesco Negro; Yusuf Yilmaz; Manuel Romero-Gomez; Jacob George; Aijaz Ahmed; Robert Wong; Issah Younossi; Mariam Ziayee; Arian Afendy
Journal:  Clin Gastroenterol Hepatol       Date:  2018-06-14       Impact factor: 11.382

Review 6.  Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes.

Authors:  Zobair M Younossi; Aaron B Koenig; Dinan Abdelatif; Yousef Fazel; Linda Henry; Mark Wymer
Journal:  Hepatology       Date:  2016-02-22       Impact factor: 17.425

7.  Effect of magnesium sulfate administration to improve insulin resistance in type 2 diabetes animal model: using the hyperinsulinemic-euglycemic clamp technique.

Authors:  Shahla Sohrabipour; Mohammad Reza Sharifi; Mohammadreza Sharifi; Ardeshir Talebi; Nepton Soltani
Journal:  Fundam Clin Pharmacol       Date:  2018-07-04       Impact factor: 2.748

Review 8.  Nonalcoholic fatty liver disease: relationship to insulin sensitivity and oxidative stress. Treatment approaches using vitamin E, magnesium, and betaine.

Authors:  Lyn Patrick
Journal:  Altern Med Rev       Date:  2002-08

9.  Magnesium supplementation reduces development of diabetes in a rat model of spontaneous NIDDM.

Authors:  T W Balon; J L Gu; Y Tokuyama; A P Jasman; J L Nadler
Journal:  Am J Physiol       Date:  1995-10

Review 10.  Nonalcoholic fatty liver disease, hepatic insulin resistance, and type 2 diabetes.

Authors:  Andreas L Birkenfeld; Gerald I Shulman
Journal:  Hepatology       Date:  2014-02       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.